Leading source of Financial News, Investor Forums, CEO Interviews, Financial Columnists, Stock Information

Add to MyProactive

pot leaf sunlight

Buds & Duds: Cannabis stocks finish the week in positive territory; Canopy Growth delays infused beverages launch

2 days, 7 hours ago

Newspapers and laptop

Industry & services

NA Proactive news snapshot: WeedMD, Minera Alamos, Exactus, Quantum Computing UPDATE ...

3 days, 1 hour ago

Aequus Pharmaceuticals Inc. -

Aequus Pharmaceuticals hails further boost to its growing Sandoz tacrolimus revenues across Canada

3 days, 8 hours ago

Boardroom

Exactus names non-profit-centric advisory firm exec to its board of directors

3 days, 10 hours ago

cannabis us dollar

Buds & Duds: Investors cheer as Organigram doubles revenue, beats expectations in quarterly results

4 days, 7 hours ago

Resolution - Enzychem Lifesciences advancing its therapy derived from deer antlers

Enzychem Lifesciences advancing its therapy derived from deer antlers

4 days, 23 hours ago

cannabis us dollar

Buds & Duds: Lexaria Bioscience shines while Aphria tumbles on slashed revenue outlook

5 days, 6 hours ago

$100 bills

Matinas BioPharma brings in $50M to fund drug development

5 days, 6 hours ago

Strand of DNA

Co-Diagnostics' genetic detection technology on display at international agriculture conference

5 days, 10 hours ago

CytoDyn Inc. - CytoDyn files for breakthrough therapy status for leronlimab in metastatic triple-negative breast cancer

CytoDyn files for breakthrough therapy status for leronlimab in metastatic triple-negative breast cancer

6 days, 4 hours ago

VolitionRx -

VolitionRx introduces new magnetic particle-based Nu.Q assay format

6 days, 8 hours ago

Orgenesis - Orgenesis taps industry veteran Mario Philips as company director

Orgenesis taps industry veteran Mario Philips as company director

6 days, 8 hours ago

close up of pills

Antibe Therapeutics bolsters executive team in preparation for ATB-346 commercialization

6 days, 9 hours ago

Doctor looking at two monitors

Zynerba hits enrollment target for Phase 2 autism study of CBD-based Zygel

6 days, 9 hours ago

Acasti Pharma Inc -

Acasti Pharma says further analysis underway after TRILOGY 1 topline results show unexpected placebo effect

6 days, 10 hours ago

Cannabis stock board

Buds & Duds: Cannabis stocks slip, Aurora takes hit on major analyst downgrade

1 week, 2 days ago

Aequus Pharmaceuticals Inc. - Aequus Pharmaceuticals Inc to broaden reimbursement for glaucoma-treatment product Vistitan in Quebec and British Columbia

Aequus to broaden patient reimbursement in Canada for glaucoma-treatment product Vistitan

1 week, 2 days ago

VolitionRx - VolitionRx Limited subsidiary Belgian Volition SPRL closes on acquisition of epigenetic reagent company Octamer GmbH for $725,000 (€650,000) in cash and stock

VolitionRx subsidiary closes on $725K acquisition of Octamer GmbH

1 week, 2 days ago

Medical worker using tablet and smartphone

Seelos Therapeutics releases interim study data validating the safety of its ketamine depression drug

1 week, 2 days ago

Orgenesis - Orgenesis adds UC Davis to its point-of-care network for developing cell, gene therapy products

Orgenesis adds UC Davis to its point-of-care network for developing cell, gene therapy products

1 week, 2 days ago